Home Companies GSK

GSK

Pol Theta Helicase Development Deal with GSK Has Potential to Add Nearly $1 Billion to Ideaya Bio’s Coffers
Combination Therapies

Pol Theta Helicase Development Deal with GSK Has Potential to Add Nearly $1 Billion to Ideaya Bio’s Coffers

0
GSK’s Jemperli Delivers 100% Response in Rectal Cancer
Companies

GSK’s Jemperli Delivers 100% Response in Rectal Cancer

0
“Refined” COVID-19 Vaccine Program of Sanofi and GSK Launches Phase II Trial
Companies

“Refined” COVID-19 Vaccine Program of Sanofi and GSK Launches Phase II Trial

0
23andMe to go Public via VG Acquisition Corp. Merger
23andMe

23andMe to go Public via VG Acquisition Corp. Merger

0
“Warp Speed” Plows $2.1B into Supporting Sanofi, GSK COVID-19 Vaccine Trial
Companies

“Warp Speed” Plows $2.1B into Supporting Sanofi, GSK COVID-19 Vaccine Trial

0
FDA Approves Myriad’s myChoice CDx for Zejula’s Late-Line Ovarian Cancer Indication
Companies

FDA Approves Myriad’s myChoice CDx for Zejula’s Late-Line Ovarian Cancer Indication

0
UK Joins Biopharmas, Wellcome on £200M Project to Complete UK Biobank Sequencing
Amgen

UK Joins Biopharmas, Wellcome on £200M Project to Complete UK Biobank Sequencing

0
CRISPR Pioneers Partner with GSK to Launch Laboratory for Genomics Research
Companies

CRISPR Pioneers Partner with GSK to Launch Laboratory for Genomics Research

0
23andMe Wins $300M Investment from GSK in Parkinson’s Disease Partnership
23andMe

23andMe Wins $300M Investment from GSK in Parkinson’s Disease Partnership

Alex Philippidis -
0
Regeneron-Led Consortium to Accelerate Sequencing of 500K Samples via UK Biobank
Abbvie

Regeneron-Led Consortium to Accelerate Sequencing of 500K Samples via UK Biobank

Alex Philippidis -
0
12Page 1 of 2

Trending

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Study Defines Four Distinct Phenotypes of Long COVID

Study Defines Four Distinct Phenotypes of Long COVID

Rare Mutations Confer Risk of Common Diseases

Rare Mutations Confer Risk of Common Diseases

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine